Tirzepatide in Miami —
twice the mechanism, superior results.
The active ingredient in Mounjaro® and Zepbound®. Targets two hunger hormones simultaneously. Clinical trials show up to 22% body weight reduction[1] — the highest of any approved medication.
✅ Great news! We ship directly to New York — Start your program today
Nationwide Tirzepatide Delivery
Professional medical weight loss from Miami to your doorstep
Start your tirzepatide program from anywhere in the US. Our board-certified Miami physicians provide telehealth consultations and prescribe compounded tirzepatide with temperature-controlled shipping to ensure medication potency. Includes Alaska, Hawaii, and Puerto Rico.
Fresh, individual vials vs. shared compounds — your safety matters.
Most clinics use shared compound vials where multiple patients draw from the same bottle. We use individual vials sized specifically for your prescription. Here's why that matters for your health and results.
Other Clinics: Shared Compounds
- Multiple patients use the same vial — contamination risk
- Unknown storage conditions — may be expired, recalled, or sitting out unrefrigerated
- Inconsistent dosing — different potency each time depending on vial age
- Hidden pricing — you never know what you're actually paying per dose
Our Individual Vials
- Fresh vial sized specifically for your exact prescription
- Guaranteed sterility with proper refrigerated storage and clear expiration dates
- Consistent potency — reliable medication strength every single dose
- Transparent pricing — you know exactly what each dose costs upfront
How Our Transparent Pricing Math Works
We make pricing crystal clear because you deserve to know exactly what you're paying and why. Here's the simple math:
Example: If you're prescribed 2.5mg weekly, we provide a 33.2mg vial that gives you 13 doses (13 weeks worth). At $450 per vial ÷ 13 doses = $34 per dose, or $138 per month.
No hidden fees. No surprises. Starting from $34/dose.
We only offer 3 vial sizes and the dose escalation follows medical protocols — not patient preference. Here's exactly what you can expect to pay.
Available Tirzepatide Vial Sizes
We help you choose the most cost-effective vial size based on your prescribed weekly dose.
Complete Tirzepatide Pricing Breakdown
Every dose clearly calculated — no hidden math or fees
Starting & Escalation Doses
Maintenance & Maximum Doses
Why You Can't Just "Request" a Specific Dose
Medical safety requires gradual dose escalation. Tirzepatide starts at 2.5mg weekly and increases by 2.5mg every 4 weeks based on your body's response and tolerance. This isn't like ordering from a restaurant menu — it's personalized medical treatment supervised by board-certified providers.
Most patients find their effective maintenance dose between 2.5mg - 7.5mg weekly, but doses up to 15mg are available for those who need higher levels for optimal results.
Ready to start with transparent pricing and individual vials? Your free consultation will determine your starting dose and vial size.
While others target one pathway, tirzepatide targets two.
Semaglutide works on GLP-1 receptors. Tirzepatide does that — and also activates GIP receptors, which enhances insulin response, improves how your body processes nutrients, and may increase energy expenditure.[2] The result is greater weight loss than any single-action treatment.
GLP-1 activation
Reduces appetite, slows digestion, regulates blood sugar — the proven foundation.
GIP activation (the game changer)
Enhances insulin response and may increase energy expenditure — amplifying results beyond GLP-1 alone.
Synergistic effect
The combination produces results greater than either pathway alone. Clinical trials confirm 20–25% average weight loss.
Proven by rigorous clinical trials.
Tirzepatide's dual-action efficacy is supported by multiple large-scale studies published in top-tier medical journals.
SURMOUNT-1 Trial[1]
N Engl J Med, 2022
2,539 adults with obesity received tirzepatide 5, 10, or 15 mg weekly. Results: 15.0%, 19.5%, and 20.9% mean weight reduction respectively vs 3.1% with placebo at 72 weeks.
View on PubMedSURPASS-1 Trial[2]
Lancet, 2021
478 adults with type 2 diabetes. Tirzepatide achieved HbA1c reductions of 1.87–2.07% and weight loss of 7–9.5 kg, demonstrating superior glycemic control and weight reduction.
View on PubMedSURPASS-5 Trial[3]
JAMA, 2022
475 adults with type 2 diabetes on insulin glargine. Tirzepatide added to insulin produced HbA1c reduction of 2.11–2.40% and significant weight loss vs placebo.
View on PubMedUnderstanding the difference.
Both are excellent. Here's how they compare so you can make an informed choice.
Not sure which is right for you? We'll help you decide — no pressure.
Start Today — Get Your PricingComprehensive health transformation.
Maximum weight loss
Up to 25% total body weight loss — the highest of any FDA-approved medication.
Cardiovascular protection
Significant improvements in blood pressure, cholesterol, and heart health markers.
Superior blood sugar control
Dual-action mechanism provides better glucose regulation than single-action treatments.
Powerful appetite control
Dramatically reduced hunger and cravings make healthy eating feel effortless.
Enhanced energy
As weight drops and metabolism improves, energy levels rise dramatically.
Quality of life
Improved confidence, mobility, sleep quality, and overall life satisfaction.
Tirzepatide results Miami — before & after.
Real patients. Real results. These are tirzepatide before and after transformations from actual Miami-Dade patients treated at our clinic — not stock photos, not paid models. Every result below was achieved under full medical supervision.
Carlos M.
Doral, FL · Age 44
-54 lbs
8 months
Dose: 10mg weekly
Weights: 247 lbs → 193 lbs
"I had tried everything. Tirzepatide changed my life. Down 54 lbs and off two blood pressure meds."
Maria R.
Kendall, FL · Age 38
-49 lbs
7 months
Dose: 7.5mg weekly
Weights: 212 lbs → 163 lbs
"After my second kid I could not lose the weight no matter what. Tirzepatide Miami — I Googled it and found this clinic. Best decision."
David T.
Hialeah, FL · Age 51
-65 lbs
10 months
Dose: 12.5mg weekly
Weights: 278 lbs → 213 lbs
"My doctor said I needed to lose weight or face surgery. I chose Tirzepatide. 65 lbs gone. No surgery. This is real."
Medical Disclaimer: Individual results vary. These tirzepatide before and after transformations are from actual patients and reflect results achieved under full medical supervision with proper dose escalation. Weight loss results depend on individual patient compliance, starting weight, health conditions, and treatment duration. FDA-approved compounded tirzepatide is prescribed based on individual medical evaluation.
Common questions about tirzepatide.
Clinical trials show tirzepatide produces greater average weight loss (20–25% vs. 15–22%) due to its dual-action mechanism. "Better" depends on your individual health profile and goals — we'll help you decide during your free consultation.
Similar to semaglutide: mild nausea, occasional digestive discomfort in the first few weeks. These decrease significantly as your body adjusts. Starting at a low dose minimizes side effects.
Most patients notice reduced appetite within the first week. Visible weight loss typically begins in weeks 2–4. Maximum results are usually achieved by 6–9 months of treatment.
Yes — many patients who plateau on semaglutide experience renewed weight loss when switching to tirzepatide's dual-action formula. We'll create a smooth transition plan.
Not recommended if you have a personal or family history of medullary thyroid carcinoma or MEN2. We conduct a thorough medical evaluation to ensure it's safe for you.
We're fully transparent about pricing — no hidden fees. Starting from $34/dose with our individual vial system. Call us or book a free consultation and we'll walk you through costs and payment options upfront.
Clinical References
Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
PubMedRosenstock J, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021;398(10295):143-155.
PubMedDahl D, et al. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA. 2022;327(6):534-545.
PubMedReady for next-generation weight loss?
Free consultation. No commitment. Real Miami doctors who answer your questions honestly.
Explore other treatments